prof. dr. Marc Van Eijkeren

Journal Article

Computed chest radiography for total body irradiation: image quality and clinical feasibility

Quentin Bouchez (UGent) , Dirk Vandenbroucke, Geert Pittomvils (UGent) , Tom Boterberg (UGent) , Marc Van Eijkeren (UGent) , Paul Leblans and Barbara Vanderstraeten (UGent)

(2024) Biomedical Physics & Engineering Express. 10(4).

Add to list

Journal Article
A1
open access

Incidence and radiotherapy treatment patterns of complicated bone metastases

Cedric Peters, Julie Vandewiele (UGent) , Yolande Lievens (UGent) , Marc Van Eijkeren (UGent) , Tom Boterberg (UGent) , Pieter Deseyne, Liv Veldeman (UGent) , Wilfried De Neve (UGent) , Christel Monten (UGent) , Sabine Braems (UGent) , et al.

(2024) JOURNAL OF BONE ONCOLOGY. 44.

Add to list

Journal Article
A1
open access

Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy : the Lung PLUS study

Lotte van der Weijst, Renée Bultijnck (UGent) , Axel Van Damme, Vincent Huybrechts (UGent) , Marc Van Eijkeren (UGent) and Yolande Lievens (UGent)

(2023) FRONTIERS IN ONCOLOGY. 13.

Add to list

Journal Article
A2
open access

Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk

Noémie Johnston, Jeffrey De Rycke (UGent) , Yolande Lievens (UGent) , Marc Van Eijkeren (UGent) , Jan Aelterman (UGent) , Eva Vandersmissen, Stephan Ponte and Barbara Vanderstraeten (UGent)

(2022) PHYSICS & IMAGING IN RADIATION ONCOLOGY. 23. p.109-117

Add to list

Journal Article
A1
open access

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Paolo Zunino, Liv Veldeman (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , Christopher J. Talbot, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 159. p.241-248

Add to list

Impact of evaluation-decision form in lung cancer patients receiving stereotactic body radiotherapy

Renée Bultijnck (UGent) , Axel Van Damme, Frederik Vanhoutte (UGent) , Elhaseen Elamin, Katrien Vandecasteele (UGent) , Patrick Berkovic, Marc Van Eijkeren (UGent) and Yolande Lievens (UGent)

(2021) RADIOTHERAPY AND ONCOLOGY. 161(Suppl 1). p.S1691-S1691

Add to list

Journal Article
A1
open access

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Cedric Peters, Julie Vandewiele (UGent) , Yolande Lievens (UGent) , Marc Van Eijkeren (UGent) , Valerie Fonteyne (UGent) , Tom Boterberg (UGent) , Pieter Deseyne, Liv Veldeman (UGent) , Wilfried De Neve (UGent) , Christel Monten (UGent) , et al.

(2021) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 27. p.64-69

Add to list

Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Cedric Peters, Julie Vandewiele (UGent) , Yolande Lievens (UGent) , Marc Van Eijkeren (UGent) , Valerie Fonteyne (UGent) , Tom Boterberg (UGent) , Pieter Deseyne, Liv Veldeman (UGent) , Wilfried De Neve (UGent) , Christel Monten (UGent) , et al.

(2020) RADIOTHERAPY AND ONCOLOGY. 152(Suppl 1). p.S663-S663

Add to list

Journal Article
A1
open access

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Ana Carballo, et al.

(2019) Radiotherapy and Oncology. 138. p.59-67

Add to list

Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Lotte van der Weijst, Renée Bultijnck (UGent) , Axel Van Damme, Marc Van Eijkeren (UGent) , Veerle Surmont (UGent) and Yolande Lievens (UGent)

(2019) RADIOTHERAPY AND ONCOLOGY. 133(suppl. 1). p.S103-S103

Academic Bibliography

prof. dr. Marc Van Eijkeren

Computed chest radiography for total body irradiation: image quality and clinical feasibility

Incidence and radiotherapy treatment patterns of complicated bone metastases

Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy : the Lung PLUS study

Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Impact of evaluation-decision form in lung cancer patients receiving stereotactic body radiotherapy

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study

Contents

Support

Contact